AIA
AIMZ Investment Advisors Portfolio holdings
AUM
$299M
This Quarter Return
+11.3%
1 Year Return
+12.69%
3 Year Return
+66.69%
5 Year Return
+124.55%
10 Year Return
+294.34%
AUM
$257M
AUM Growth
+$257M
(+16%)
Cap. Flow
+$12.9M
Cap. Flow
% of AUM
5.02%
Top 10 Holdings %
Top 10 Hldgs %
33.45%
Holding
121
New
8
Increased
57
Reduced
23
Closed
2
Top Buys
| 1 |
Protolabs
PRLB
|
$3.47M |
| 2 |
Incyte
INCY
|
$2.51M |
| 3 |
CDK
CDK Global, Inc.
CDK
|
$584K |
| 4 |
Emergent Biosolutions
EBS
|
$557K |
| 5 |
Teva Pharmaceuticals
TEVA
|
$531K |
Top Sells
| 1 |
Palantir
PLTR
|
$215K |
| 2 |
Allstate
ALL
|
$204K |
| 3 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$76.6K |
| 4 |
AT&T
T
|
$53.1K |
| 5 |
Invesco QQQ Trust
QQQ
|
$45.7K |
Sector Composition
| 1 | Technology | 32.7% |
| 2 | Healthcare | 27.96% |
| 3 | Industrials | 12.86% |
| 4 | Financials | 7.54% |
| 5 | Consumer Discretionary | 5.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$3.45T
| $18.3M | 7.1% | 102,793 +121 | +0.1% | +$21.5K |
|
2
Microsoft
MSFT
$3.77T
| $12.2M | 4.75% | 36,266 +271 | +0.8% | +$91.1K |
|
3
Qualcomm
QCOM
$173B
| $10.1M | 3.91% | 54,985 +522 | +1% | +$95.5K |
|
4
Infosys
INFY
$69.7B
| $8.47M | 3.3% | 334,652 +1,757 | +0.5% | +$44.5K |
|
5
Regeneron Pharmaceuticals
REGN
$61.5B
| $7.21M | 2.81% | 11,424 +125 | +1% | +$78.9K |
|
6
T Rowe Price
TROW
$23.6B
| $7.05M | 2.75% | 35,871 +383 | +1% | +$75.3K |
|
7
NetApp
NTAP
$22.6B
| $6.16M | 2.4% | 66,986 +709 | +1% | +$65.2K |
|
8
Expeditors International
EXPD
$16.4B
| $5.79M | 2.25% | 43,114 +520 | +1% | +$69.8K |
|
9
Meta Platforms (Facebook)
META
$1.86T
| $5.45M | 2.12% | 16,215 -39 | -0.2% | -$13.1K |
|
10
Vertex Pharmaceuticals
VRTX
$100B
| $5.29M | 2.06% | 24,080 +400 | +2% | +$87.8K |
|
11
Gilead Sciences
GILD
$140B
| $5.09M | 1.98% | 70,031 +1,262 | +2% | +$91.6K |
|
12
C.H. Robinson
CHRW
$15.2B
| $5.08M | 1.98% | 47,214 +804 | +2% | +$86.5K |
|
13
Cisco
CSCO
$274B
| $4.85M | 1.89% | 76,516 -544 | -0.7% | -$34.5K |
|
|
14
Incyte
INCY
$16.5B
| $4.37M | 1.7% | 59,532 +34,222 | +135% | +$2.51M |
|
15
GSK
GSK
$79.9B
| $4.27M | 1.66% | 96,809 +2,310 | +2% | +$102K |
|
|
WBA
16
DELISTED
Walgreens Boots Alliance
WBA
| $4.02M | 1.57% | 77,084 +1,763 | +2% | +$92K |
|
17
Adobe
ADBE
$151B
| $3.85M | 1.5% | 6,790 -75 | -1% | -$42.5K |
|
18
AstraZeneca
AZN
$248B
| $3.8M | 1.48% | 65,295 +1,487 | +2% | +$86.6K |
|
19
UnitedHealth
UNH
$281B
| $3.75M | 1.46% | 7,474 -4 | -0.1% | -$2.01K |
|
20
Cintas
CTAS
$84.6B
| $3.72M | 1.45% | 8,387 +200 | +2% | +$88.6K |
|
21
Lowe's Companies
LOW
$145B
| $3.66M | 1.42% | 14,140 +202 | +1% | +$52.2K |
|
22
Berkshire Hathaway Class B
BRK.B
$1.09T
| $3.58M | 1.39% | 11,964 | – | – |
|
23
Franklin Resources
BEN
$13.3B
| $3.57M | 1.39% | 106,628 +1,916 | +2% | +$64.2K |
|
|
24
Protolabs
PRLB
$1.19B
| $3.47M | 1.35% | +67,528 | New | +$3.47M |
|
25
Amgen
AMGN
$155B
| $3.45M | 1.34% | 15,354 +401 | +3% | +$90.2K |
|